These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 18344932)

  • 1. Intentional conversion from tacrolimus to cyclosporine for HCV-positive patients on preemptive interferon therapy after living donor liver transplantation.
    Eguchi S; Takatsuki M; Soyama A; Hidaka M; Tokai H; Hamasaki K; Miyazaki K; Tajima Y; Ichikawa T; Kanematsu T
    Ann Transplant; 2007; 12(4):11-5. PubMed ID: 18344932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.
    Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S
    Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine a-based immunosuppression reduces relapse rate after antiviral therapy in transplanted patients with hepatitis C virus infection: a large multicenter cohort study.
    ReViS-TC Study Group
    Transplantation; 2011 Aug; 92(3):334-40. PubMed ID: 21659948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C.
    Ross AS; Bhan AK; Pascual M; Thiim M; Benedict Cosimi A; Chung RT
    Clin Transplant; 2004 Apr; 18(2):166-73. PubMed ID: 15016131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily low-dose tacrolimus is a safe and effective immunosuppressive regimen during telaprevir-based triple therapy for hepatitis C virus recurrence after liver transplant.
    Papadopoulos-Köhn A; Achterfeld A; Paul A; Canbay A; Timm J; Jochum C; Gerken G; Herzer K
    Transplantation; 2015 Apr; 99(4):841-7. PubMed ID: 25208324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic rejection associated with antiviral therapy for recurrent hepatitis C after living-donor liver transplantation.
    Ueda Y; Kaido T; Ito T; Ogawa K; Yoshizawa A; Fujimoto Y; Mori A; Miyagawa-Hayashino A; Haga H; Marusawa H; Chiba T; Uemoto S
    Transplantation; 2014 Feb; 97(3):344-50. PubMed ID: 24157473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination.
    Dumortier J; Scoazec JY; Chevallier P; Boillot O
    J Hepatol; 2004 Apr; 40(4):669-74. PubMed ID: 15030984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot study.
    Firpi RJ; Soldevila-Pico C; Morelli GG; Cabrera R; Levy C; Clark VC; Suman A; Michaels A; Chen C; Nelson DR
    Dig Dis Sci; 2010 Jan; 55(1):196-203. PubMed ID: 19798576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptosporidiosis in a patient on PEG-interferon and ribavirin for recurrent hepatitis C after living donor liver transplantation.
    Manz M; Steuerwald M
    Transpl Infect Dis; 2007 Mar; 9(1):60-1. PubMed ID: 17313476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantation.
    Zimmermann T; Böcher WO; Biesterfeld S; Zimmermann A; Kanzler S; Greif-Higer G; Barreiros AP; Sprinzl MF; Wörns MA; Lohse AW; Mönch C; Otto G; Galle PR; Schuchmann M
    Transpl Int; 2007 Jul; 20(7):583-90. PubMed ID: 17433090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C.
    Angelico M; Petrolati A; Lionetti R; Lenci I; Burra P; Donato MF; Merli M; Strazzabosco M; Tisone G
    J Hepatol; 2007 Jun; 46(6):1009-17. PubMed ID: 17328985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preemptive antiviral treatment for hepatitis C virus after living donor liver transplantation.
    Sugawara Y; Tamura S; Yamashiki N; Kaneko J; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N
    Transplant Proc; 2012 Apr; 44(3):791-3. PubMed ID: 22483497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peginterferon alfa-2b plus ribavirin for the treatment of hepatitis C recurrence following combined liver and kidney transplantation.
    Schmitz V; Kiessling A; Bahra M; Puhl G; Kahl A; Berg T; Neuhaus R; Neuhaus P; Neumann U
    Ann Transplant; 2007; 12(3):22-7. PubMed ID: 18290566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon alpha 2b and ribavirin for the treatment of recurrent hepatitis C after liver transplantation: cohort study of 38 patients.
    Mukherjee S; Lyden E; McCashland TM; Schafer DF
    J Gastroenterol Hepatol; 2005 Feb; 20(2):198-203. PubMed ID: 15683421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin.
    Stanca CM; Fiel MI; Kontorinis N; Agarwal K; Emre S; Schiano TD
    Transplantation; 2007 Jul; 84(2):180-6. PubMed ID: 17667809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon.
    Jain A; Demetris AJ; Manez R; Tsamanadas AC; Van Thiel D; Rakela J; Starzl TE; Fung JJ
    Liver Transpl Surg; 1998 May; 4(3):197-203. PubMed ID: 9563957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus and cyclosporin doses and blood levels in hepatitis C and alcoholic liver disease patients after liver transplantation.
    Oo YH; Dudley T; Nightingale P; Haydon G; Mutimer D
    Liver Transpl; 2008 Jan; 14(1):81-7. PubMed ID: 18161844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma ribavirin concentrations during treatment of recurrent hepatitis C with peginterferon alpha-2b and ribavirin combination after liver transplantation.
    Dumortier J; Ducos E; Scoazec JY; Chevallier P; Boillot O; Gagnieu MC
    J Viral Hepat; 2006 Aug; 13(8):538-43. PubMed ID: 16901284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients.
    Castells L; Esteban JI; Bilbao I; Vargas V; Allende H; Ribera E; Piron M; Sauleda S; Len O; Pahissa A; Esteban R; Guardia J; Margarit C
    Antivir Ther; 2006; 11(8):1061-70. PubMed ID: 17302376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of immunosuppressive monotherapy in liver transplantation: tacrolimus and microemulsified cyclosporin.
    Cholongitas E; Shusang V; Germani G; Tsochatzis E; Raimondo ML; Marelli L; Senzolo M; Davidson BR; Patch D; Rolles K; Burroughs AK
    Clin Transplant; 2011; 25(4):614-24. PubMed ID: 20718824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.